EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older

Leandra A A Ros iD, Boudewijn T H M Sleutjes, H Stephan Goedee iD, Fay-Lynn Asselman, Inge Cuppen, Ruben P A van Eijk, W Ludo van der Pol, Renske I Wadman

Muscle & Nerve · 2025

DOI: 10.1002/mus.28384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2025. Verfasst von Leandra A A Ros und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Medical Center Utrecht, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Action Potentials, Muscular Atrophy, Spinal, Median Nerve, Sensory Receptor Cells. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Stichting Spieren voor Spieren, Prinses Beatrix Spierfonds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims Survival Motor Neuron 1 (SMN1) ‐related spinal muscular atrophy (SMA) is characterized by α‐motor neuron degeneration, with sensory function assumed to be clinically preserved. However, recent studies in severely affected patients and animal models have challenged this view. Therefore, we assessed the maximum sensory nerve action potential (SNAP) amplitude of the median nerve in patients with SMA and examined its changes during treatment with SMN ‐splicing modifying therapies.

Methods

We longitudinally assessed median nerve maximum SNAPs in 103 genetically confirmed patients with SMA (types 1c‐4, aged ≥ 12 years) before and approximately 1 year after treatment with nusinersen or risdiplam. For comparison, we included 53 age‐ and sex‐matched healthy controls, using identical settings. We also compared data with reference values from a previously published cohort.

Results

Maximum SNAPs were abnormal in 6 patients with SMA (6%), which was comparable to controls (8%), even when corrected for age. In patients younger than 50 years, abnormal maximum SNAPs were more prevalent in patients with SMA types 1 and 2. Maximum SNAPs were higher in SMA compared with controls. Maximum SNAPs showed an age‐related decline in most cohorts, but the decline was steeper in patients with SMA type 1c. There was no difference in SNAPs after 1 year of treatment.

Discussion

Our findings suggest the preserved sensory integrity of the median nerve in the majority of patients with SMA (94%), even in longstanding disease. The resilience of sensory neurons of the median nerve, and whether this extends to other peripheral nerves, warrants further investigation. Trial Registration: The study was approved by the local medical ethics committee (no. 20‐143) and registered in the Dutch registry for clinical studies and trials ( www.toetsingonline.nl —NL72562.041.20, March 26, 2020)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Action PotentialsMuscular Atrophy, SpinalMedian NerveSensory Receptor CellsHumansMaleFemaleChildAdultAdolescentMiddle AgedYoung AdultCohort StudiesLongitudinal StudiesAgedOligonucleotidesNeural ConductionAzo CompoundsPyrimidines

Stichwörter der Autor:innen

SMN‐modulating therapyelectrophysiologysensory nerve action potentialspinal muscular atrophy

Substanzen

nusinersenOligonucleotidesRisdiplamAzo CompoundsPyrimidines

Autor:innen und Institutionen

  • Department of Neurology, University Medical Center Utrecht, UMC Utrecht Brain Center, Utrecht University, Utrecht, the Netherlands.
  • Biostatistics and Research Support, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.

ORCID-Profile: Leandra A A Ros, H Stephan Goedee

Förderung

  • Stichting Spieren voor Spieren
  • Prinses Beatrix Spierfonds

Zitieren

APA

Ros, L. A. A., Sleutjes, B. T. H. M., Goedee, H. S., Asselman, F. L., Cuppen, I., van Eijk, R. P. A., van der Pol, W. L., & Wadman, R. I. (2025). Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older. Muscle & Nerve. https://doi.org/10.1002/mus.28384

Vancouver

Ros LAA, Sleutjes BTHM, Goedee HS, Asselman FL, Cuppen I, van Eijk RPA, et al. Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older. Muscle & Nerve. 2025. doi:10.1002/mus.28384

BibTeX
@article{Ros2025,
  author = {Ros, Leandra A A and Sleutjes, Boudewijn T H M and Goedee, H Stephan and Asselman, Fay-Lynn and Cuppen, Inge and van Eijk, Ruben P A and van der Pol, W Ludo and Wadman, Renske I},
  title = {Sensory Nerve Action Potential Analysis in a Cohort of Patients With Spinal Muscular Atrophy Aged 12 Years and Older},
  journal = {Muscle & Nerve},
  year = {2025},
  doi = {10.1002/mus.28384}
}
Kostenlos starten →